세계의 군유전체학 시장 보고서(2025년)
Metagenomics Global Market Report 2025
상품코드 : 1824293
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

군유전체학 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 14.6%를 나타내 39억 9,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 정밀의료의 통합, 미생물 생태학의 이해, 원헬스 이니셔티브, 바이오프로스펙팅과 신약 개발, 진단과 치료의 혁신에 기인한다고 생각됩니다. 예측 기간의 주요 동향에는 시퀀싱 기술 진보, AI와 머신러닝 통합, 단일 셀 군유전체학, 메타유전체 데이터의 표준화, 소비자 웰니스, 맞춤형 영양 등이 포함됩니다.

향후 5년간의 성장률 14.6%라고 하는 예측은 전회의 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 부과는 한국과 프랑스에서 공급되는 자동 DNA 추출 시스템과 바이오인포매틱스 소프트웨어의 비용을 상승시킴으로써 미국의 마이크로바이옴 연구를 혼란시켜 장뇌축 연구를 손상시킬 가능성과 학술 연구 예산을 증가시킬 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

감염증의 이환율 증가는 군유전체학 시장 확대에 기여하는 주요 요인입니다. 감염은 종종 전염성 질환이라고 불리며, 박테리아, 바이러스, 곰팡이, 기생충과 같은 병원성 미생물에 의해 유발되는 질병으로 사람에서 사람으로 또는 다양한 감염 경로를 통해 전파됩니다. 군유전체학는 미생물 군중의 유전 물질을 분석함으로써 감염의 연구에 중요한 역할을 합니다. 이 접근법은 감염성 병원체와 관련된 미생물 군중을 철저히 조사하여 조성, 유전적 다양성 및 잠재적 상호 작용에 대한 통찰력을 얻을 수 있습니다. 예를 들어 2024년 2월 영국 건강보건국(UK Health Security Agency)이 발표한 보고서에 따르면 잉글랜드의 결핵 환자는 2023년 10.7% 증가했으며 2022년 4,380명에 비해 4,850명을 기록했습니다. 그 결과, 감염의 확산은 군유전체학 시장 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Metagenomics is a scientific research field that explores genetic material (DNA or RNA) directly extracted from environmental samples or complex microbial communities. Rather than isolating and studying individual organisms, metagenomics focuses on analyzing the collective genomic information present in a given sample.

The primary types of products associated with metagenomics include instruments, kits and reagents, and software and services. Instruments are tools and equipment used for sample collection, DNA and RNA extraction, and various workflows such as sequencing, pre-sequencing, and data analysis. Metagenomic applications span diverse fields, including environmental studies, clinical diagnostics, drug discovery, biotechnology, food and nutrition. These products are utilized by a range of end-users, including pharmaceutical industries, research laboratories, biotechnology companies, pathology laboratories, as well as academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The metagenomics market research report is one of a series of new reports from The Business Research Company that provides metagenomics market statistics, including metagenomics industry global market size, regional shares, competitors with a metagenomics market share, detailed metagenomics market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics industry. This metagenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metagenomics market size has grown rapidly in recent years. It will grow from $2.01 billion in 2024 to $2.31 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to microbiome research advancements, disease association studies, environmental monitoring needs, agricultural and food applications, biotechnology and industrial processes.

The metagenomics market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to precision medicine integration, microbial ecology understanding, one health initiatives, bioprospecting and drug discovery, diagnostic and therapeutic innovations. Major trends in the forecast period include technological advancements in sequencing, integration of ai and machine learning, single-cell metagenomics, metagenomic data standardization, consumer wellness and personalized nutrition.

The forecast of 14.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. microbiome research by increasing costs for automated DNA extraction systems and bioinformatics software sourced from South Korea and France, potentially compromising gut-brain axis studies and increasing academic research budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing incidence of infectious diseases is a major factor contributing to the expansion of the metagenomics market. Infectious diseases, often referred to as transmissible diseases, are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites, which can be spread from person to person or through various transmission methods. Metagenomics plays a vital role in studying infectious diseases by analyzing the genetic material of microbial communities. This approach allows for a thorough examination of microbial communities linked to infectious agents, offering insights into their composition, genetic diversity, and potential interactions. For example, a report released by the UK Health Security Agency in February 2024 indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases recorded compared to 4,380 in 2022. Consequently, the rising prevalence of infectious diseases is propelling the growth of the metagenomics market.

The expanding agriculture sector is expected to drive the growth of the metagenomics market in the future. The agriculture sector, commonly known as the agricultural industry or farming sector, includes a wide range of activities related to crop cultivation, livestock rearing, and the production of food, fiber, and other agricultural products. Metagenomics enhances precision agriculture by providing insights into microbial communities, enabling farmers to make informed decisions regarding resource management, irrigation, and pest control. For example, a report from the Plant Based Foods Association in January 2023 indicated that plant-based food sales grew by 6.6% in 2022, an increase from 5.9% in 2021, alongside a 10% rise in average retail prices. Thus, the growth of the agriculture sector is fueling the expansion of the metagenomics market.

A prominent trend in the metagenomics market is the adoption of technological advancements. Major companies in the market are actively embracing new genomics technologies to enhance their observational capabilities and maintain their market position. For instance, CD Genomics, a genomics services company based in the US, introduced the Long-Read Metagenomic Sequencing service in May 2023. This cutting-edge technology empowers researchers and scientists to gain a deeper and more accurate understanding of microbial communities. With features such as enhanced resolution, species identification, functional annotation, and comparative analysis, this advanced method is expected to revolutionize metagenomics research by providing unprecedented insights into microbial communities.

Leading companies in the metagenomics market are also focusing on developing innovative products, such as production-scale sequencers, to cater to larger customer bases, increase sales, and boost revenue. A production-scale sequencer is designed for high-throughput DNA sequencing tasks on a large scale. In September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series (NovaSeq X and NovaSeq X Plus). These sequencers enable quicker, more potent, and environmentally sustainable sequencing. The NovaSeq X Plus, in particular, has the capacity to generate over 20,000 whole genomes annually, showcasing a throughput 2.5 times greater than its predecessors. The efficiency increase accelerates genomic discovery, enhances clinical insights, and contributes to a deeper understanding of diseases. Additionally, the NovaSeq X exhibits a strong commitment to environmental sustainability by significantly reducing packaging waste and weight, along with a 50% reduction in plastic usage compared to its predecessor, the NovaSeq 6000.

In June 2022, Illumina Inc. acquired IDbyDNA, a US-based biotechnology company specializing in metagenomic technology for infectious disease testing and pathogen surveillance, for an undisclosed amount. This acquisition is aimed at accelerating Illumina Inc.'s growth in the metagenomics market and expanding its range of solutions for customers.

Major companies operating in the metagenomics market include Illumina Inc., Promega Corporation, Qiagen N.V., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies Limited, BGI Group, Eurofins Scientific SE, Arc Bio LLC, Computomics GmbH, Enterome Bioscience, TAKARA BIO INC., Danaher Corporation, ELITechGroup, Metagenomi, Cosmosid Inc., Pattern Ag, Tiny Health, MATIS OHF, Adapsyn Bioscience, Precidiag Inc., One Codex Inc., MetaBi Inc., Zymo Research Corporation, Bluebee Holding BV, Maverix Biomics Inc., Lucigen Corporation

North America was the largest region in the global metagenomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the metagenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The metagenomics market consists of revenues earned by entities by providing metagenomic services such as metatranscriptome sequencing, microbial genome sequencing, functional analysis, comparative metagenomics, and metatranscriptomics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metagenomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metagenomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for metagenomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metagenomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Metagenomics Market Characteristics

3. Metagenomics Market Trends And Strategies

4. Metagenomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Metagenomics Growth Analysis And Strategic Analysis Framework

6. Metagenomics Market Segmentation

7. Metagenomics Market Regional And Country Analysis

8. Asia-Pacific Metagenomics Market

9. China Metagenomics Market

10. India Metagenomics Market

11. Japan Metagenomics Market

12. Australia Metagenomics Market

13. Indonesia Metagenomics Market

14. South Korea Metagenomics Market

15. Western Europe Metagenomics Market

16. UK Metagenomics Market

17. Germany Metagenomics Market

18. France Metagenomics Market

19. Italy Metagenomics Market

20. Spain Metagenomics Market

21. Eastern Europe Metagenomics Market

22. Russia Metagenomics Market

23. North America Metagenomics Market

24. USA Metagenomics Market

25. Canada Metagenomics Market

26. South America Metagenomics Market

27. Brazil Metagenomics Market

28. Middle East Metagenomics Market

29. Africa Metagenomics Market

30. Metagenomics Market Competitive Landscape And Company Profiles

31. Metagenomics Market Other Major And Innovative Companies

32. Global Metagenomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metagenomics Market

34. Recent Developments In The Metagenomics Market

35. Metagenomics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기